Decreased incidence of diabetes mellitus by monosodium glutamate in the non-obese diabetic (NOD) mouse. 1985

H Nakajima, and Y Tochino, and H Fujino-Kurihara, and K Yamada, and M Gomi, and K Tajima, and T Kanaya, and A Miyazaki, and J Miyagawa, and T Hanafusa

Subcutaneous administration of monosodium glutamate (MSG) to neonatal female non-obese diabetic (NOD) mice resulted in obesity associated with stunting and hyperinsulinemia. However, the cumulative incidence of diabetes mellitus at 25 weeks of age in the MSG group was significantly lower than in the control group (10.3% vs. 43.6%, P less than 0.005). The immunoreactive insulin content of the pancreas from the 13- to 20-week-old MSG-treated mice was higher than that of the control mice (P less than 0.005). Immunohistochemistry showed that the number of pancreatic B-cells was well preserved and insulitis was attenuated in the MSG-treated mice. Plasma corticosterone and 3, 5, 3'-triiodothyronine levels were elevated in the MSG group. These results suggested that, by the MSG treatment, the B-cell functions were maintained through the modification of the degenerative process of the islets in the NOD mouse.

UI MeSH Term Description Entries
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D005260 Female Females
D005971 Glutamates Derivatives of GLUTAMIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the 2-aminopentanedioic acid structure. Glutamic Acid Derivatives,Glutamic Acids,Glutaminic Acids
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals
D012970 Sodium Glutamate One of the FLAVORING AGENTS used to impart a meat-like flavor. MSG,Monosodium Glutamate,Vestin,Accent,Glutamate, Sodium

Related Publications

H Nakajima, and Y Tochino, and H Fujino-Kurihara, and K Yamada, and M Gomi, and K Tajima, and T Kanaya, and A Miyazaki, and J Miyagawa, and T Hanafusa
April 2006, Experimental animals,
H Nakajima, and Y Tochino, and H Fujino-Kurihara, and K Yamada, and M Gomi, and K Tajima, and T Kanaya, and A Miyazaki, and J Miyagawa, and T Hanafusa
January 1998, Nihon rinsho. Japanese journal of clinical medicine,
H Nakajima, and Y Tochino, and H Fujino-Kurihara, and K Yamada, and M Gomi, and K Tajima, and T Kanaya, and A Miyazaki, and J Miyagawa, and T Hanafusa
August 1996, The American journal of pathology,
H Nakajima, and Y Tochino, and H Fujino-Kurihara, and K Yamada, and M Gomi, and K Tajima, and T Kanaya, and A Miyazaki, and J Miyagawa, and T Hanafusa
August 1987, The American journal of pathology,
H Nakajima, and Y Tochino, and H Fujino-Kurihara, and K Yamada, and M Gomi, and K Tajima, and T Kanaya, and A Miyazaki, and J Miyagawa, and T Hanafusa
January 2018, PloS one,
H Nakajima, and Y Tochino, and H Fujino-Kurihara, and K Yamada, and M Gomi, and K Tajima, and T Kanaya, and A Miyazaki, and J Miyagawa, and T Hanafusa
January 2016, Journal of autoimmunity,
H Nakajima, and Y Tochino, and H Fujino-Kurihara, and K Yamada, and M Gomi, and K Tajima, and T Kanaya, and A Miyazaki, and J Miyagawa, and T Hanafusa
October 1991, Scandinavian journal of immunology,
H Nakajima, and Y Tochino, and H Fujino-Kurihara, and K Yamada, and M Gomi, and K Tajima, and T Kanaya, and A Miyazaki, and J Miyagawa, and T Hanafusa
June 1993, Diabetologia,
H Nakajima, and Y Tochino, and H Fujino-Kurihara, and K Yamada, and M Gomi, and K Tajima, and T Kanaya, and A Miyazaki, and J Miyagawa, and T Hanafusa
April 1994, Immunology and cell biology,
H Nakajima, and Y Tochino, and H Fujino-Kurihara, and K Yamada, and M Gomi, and K Tajima, and T Kanaya, and A Miyazaki, and J Miyagawa, and T Hanafusa
June 1986, Life sciences,
Copied contents to your clipboard!